Zileuton

Zileuton is a member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogen at position 2 is replaced by a 1-[carbamoyl(hydroxy)amino]ethyl group. A selective 5-lipoxygenase inhibitor, it inhibits the formation of leukotrienes LTB4, LTC4, LDT4, and LTE4. It is used for the management of chronic asthma. Among its listed roles, it functions as a EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor, a non-steroidal anti-inflammatory drug, an anti-asthmatic drug, a leukotriene antagonist and a ferroptosis inhibitor. It belongs to the class of ureas and a member of 1-benzothiophenes. It is derived from a hydride of a 1-benzothiophene. It is grouped under the following drug class(es): 5-Alpha Reductase Inhibitors and Leukotriene modifiers. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zyflo, Leutrol and Zyflo CR. Its PubChem CID is 60490.

CAS No 111406-87-2
Molecular Formula C11H12N2O2S
Molecular Weight 236.29 g/mol
Synonyms 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea

Frequently Asked Questions